UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications

Nature reviews. Endocrinology, 2014-12, Vol.10 (12), p.711

Frier, Brian M

2014

Volltextzugriff (PDF)

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

Diabetes care, 2016-08, Vol.39 Suppl 2 (Supplement_2), p.S205-S209

2016

Volltextzugriff (PDF)

Diabetes and cognitive dysfunction

The Lancet (British edition), 2012, Vol.379 (9833), p.2291-2299

2012

Volltextzugriff (PDF)

Hypoglycemia and cardiovascular risks

Diabetes care, 2011-05, Vol.34 Suppl 2 (Supplement_2), p.S132-S137

2011

Volltextzugriff (PDF)

The risks of nocturnal hypoglycaemia in insulin-treated diabetes

Diabetes research and clinical practice, 2017-11, Vol.133, p.30-39

2017

Volltextzugriff (PDF)

How hypoglycaemia can affect the life of a person with diabetes

Diabetes/metabolism research and reviews, 2008-02, Vol.24 (2), p.87-92

Frier, Brian M.

2008

Volltextzugriff (PDF)

Cognitive decline in longstanding type 1 diabetes: a role for severe hypoglycaemia

The lancet. Diabetes & endocrinology, 2021-07, Vol.9 (7), p.411-412

Frier, Brian M

2021

Volltextzugriff (PDF)

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

Diabetes/metabolism research and reviews, 2008-07, Vol.24 (5), p.353-363

2008

Volltextzugriff (PDF)

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Diabetes, obesity & metabolism, 2022-10, Vol.24 (10), p.1912-1926

2022

Volltextzugriff (PDF)

Young‐onset type 2 diabetes: A neglected group requiring urgent attention

Diabetic medicine, 2022-09, Vol.39 (9), p.e14903-n/a

2022

Volltextzugriff (PDF)

Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes?

Diabetic medicine, 2023-10, Vol.40 (10), p.e15185-e15185

2023

Volltextzugriff (PDF)

Severe hypoglycaemia in adults presenting to a hospital emergency department: Clinical characteristics, comorbidities, and mortality outcomes

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2824-2834

2023

Volltextzugriff (PDF)

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

The lancet. Diabetes & endocrinology, 2019-05, Vol.7 (5), p.385-396

2019

Volltextzugriff (PDF)

Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities

Diabetes care, 2005-12, Vol.28 (12), p.2948-2961

2005

Volltextzugriff (PDF)

Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial

Diabetes, obesity & metabolism, 2024-02, Vol.26 (2), p.503-511

2024

Volltextzugriff (PDF)

Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

Diabetes care, 2014-02, Vol.37 (2), p.507-515

2014

Volltextzugriff (PDF)

Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon

Diabetes, obesity & metabolism, 2020-04, Vol.22 (4), p.469-479

2020

Volltextzugriff (PDF)

The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors

Alzheimer's research & therapy, 2015-06, Vol.7 (1), p.46-46, Article 46

2015

Volltextzugriff (PDF)

Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study

Diabetes care, 2014-12, Vol.37 (12), p.3301-3308

2014

Volltextzugriff (PDF)

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

Diabetes care, 2011-05, Vol.34 (5), p.1139-1144

2011

Volltextzugriff (PDF)

Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation: Putative mechanism for aggravating vascular disease in diabetes

Diabetes care, 2010-07, Vol.33 (7), p.1591-1597

2010

Volltextzugriff (PDF)

Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes

Diabetes research and clinical practice, 2010-01, Vol.87 (1), p.64-68

2010

Volltextzugriff (PDF)

Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL

Diabetes, obesity & metabolism, 2020-03, Vol.22 (3), p.315-323

2020

Volltextzugriff (PDF)

Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis

Diabetes therapy, 2024-08, Vol.15 (8), p.1769-1784

2024

Volltextzugriff (PDF)

Acute Hypoglycemia Impairs Executive Cognitive Function in Adults With and Without Type 1 Diabetes

Diabetes care, 2013-10, Vol.36 (10), p.3240-3246

2013

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(177)
Humans
(175)
Endocrinology & Metabolism
(125)
Diabetes
(106)
Male
(93)
Female
(83)
Adult
(82)
Hypoglycemia
(78)
Biological And Medical Sciences
(66)
Insulin
(63)
Hypoglycaemia
(62)
Medical Sciences
(59)
Endocrine Pancreas. Apud Cells
(53)
Endocrinopathies
(53)
Middle Aged
(50)
Diabetes. Impaired Glucose Tolerance
(47)
Diabetes Mellitus
(42)
Hypoglycemia - Chemically Induced
(41)
Risk Factors
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

Diabetes and cognitive dysfunction

Hypoglycemia and cardiovascular risks

The risks of nocturnal hypoglycaemia in insulin-treated diabetes

How hypoglycaemia can affect the life of a person with diabetes

Cognitive decline in longstanding type 1 diabetes: a role for severe hypoglycaemia

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Young‐onset type 2 diabetes: A neglected group requiring urgent attention

Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes?

Severe hypoglycaemia in adults presenting to a hospital emergency department: Clinical characteristics, comorbidities, and mortality outcomes

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities

Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial

Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon

The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors

Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation: Putative mechanism for aggravating vascular disease in diabetes

Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes

Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL

Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis

Acute Hypoglycemia Impairs Executive Cognitive Function in Adults With and Without Type 1 Diabetes

Suchergebnisse filtern